2026 Program

2026 Annual Scientific Meeting Program

Select the dates below to expand the program schedule. Schedule information is subject to change. Additional faculty details to be added as invitations are accepted. Last updated 29 January 2025.

Friday, 31 January 2025

Time		Session Description
8:00 - 8:45 a.m.	Breakfast and Industry Symposium presented by Inari - Mechanical Thrombectomy for the Treatment of Venous Thromboembolic Disease within the Oncology Population Milan Patel, MD, MD Anderson Cancer Center
8:45 - 10:15 a.m.	President's Welcome & Dr. Sidney Wallace and Dr. Michael J. Wallace Distinguished Lecture (All levels) President's Welcome, Muneeb Ahmed, MD, FSIR, Beth Israel Deaconess Medical Center/Harvard Medical School Program Chair's Program Overview, Nicholas Fidelman, MD, University of California San Francisco Wallace Lecturer's Laudation, Sarah B. White, MD, MS, Medical College of Wisconsin Dr. Sidney Wallace and Dr. Michael J. Wallace Distinguished Lecture - Interventional Oncology: Generations , Michael C. Soulen, MD, FSIR, FCIRSE, University of Pennsylvania Supported by an educational grant from Guerbet.
9:00 a.m. - 7:30 p.m.	Exhibit Hall Open
10:30 - 11:30 a.m.	SIO 2025: 25 Years Past and Future (All levels) Moderators: Nicholas Fidelman, MD, University of California San Francisco; Muneeb Ahmed, MD, FSIR, Beth Israel Deaconess Medical Center/Harvard Medical School Medical Devices, John Kaufman, MD, MS, OHSU/Cook Medical Basic and Translational Research, Jens Ricke, MD, LMU Munich Computational Advances, Judy Gichoya, MD, FSIM, Emory University Educating the Next Generation of Interventional Oncologists, Quinn Meisinger, MD, University of California San Diego
11:30 a.m. - 1:00 p.m.	Exhibit Hall Open
11:45 a.m. - 12:30 p.m.	Lunch and Industry Symposium presented by Interventional Oncology at Johnson & Johnson (INTO) - Novel Intratumoral Cancer Treatments and the Expanding Role of the Interventional Radiologist Moderator: Kamyar Farahi, PhD, Head, Scientific Engagement & Education, Global Scientific Affairs, INTO at J&J Harnessing Pharma and Medical Technology Expertise to Eliminate Cancer through Intratumoral Treatments, Hannah McEwen, PhD, Vice President, Engineering Sciences, INTO at J&J Understanding Unmet Needs in Cancer Treatment and Expanding IR’s Role in the Evolving Landscape, Robert Short MD, PhD, Vascular Interventional Radiologist, Associate Professor, Radiology, Surgery, Biomedical Engineering, Wright State University, Boonshoft School of Medicine
11:45 a.m. - 12:30 p.m.	Lunch and Industry Symposium presented by Sirtex - Optimization of SIR-Spheres® Y-90 Resin Microspheres for Personalized Treatment Intent Nima Kokabi, MD, FRCPC, University of North Carolina Chapel Hill Zachary Berman, MD, University of California, San Diego
12:15 - 1:00 p.m.	Discovery Theatre Programming 12:15 - 12:45 p.m. - Industry Advances (All levels) Moderators: Damian E. Dupuy, MD, FACR, Cape Cod Hospital and Brown University; Guy Johnson, MD, PharmD, University of Washington 12:45 - 1:00 p.m. - Product Theatre presented by TeleDaas - Advances in Dosimetry and Barriers to Adoption, Venkatesh Krishnasamy, MD, FCIRSE, UAB
1:00 - 2:30 p.m.	SIO Meets NANETS: Neuroendocrine Tumor Update and Tumor Board (200) Moderators: Michael C. Soulen, MD, FSIR, FCIRSE, University of Pennsylvania; Rony Avritscher, MD, MD Anderson Cancer Center Medical Therapy Updates, Heloisa Soares, MD, PhD, Huntsman Cancer Institute at University of Utah Trans-arterial Therapy Before and After PRRT, Zachary Berman, MD, University of California, San Diego Ablation: New Frontiers, Mishal Mendiratta-Lala, MD, University of Michigan Serial Biopsy: Value Added, Daniel DiPietro, MD, Perelman School of Medicine at the University of Pennsylvania Tumor Board, All session faculty listed above; Eric Nakakura, MD, PhD, University of California, San Francisco
	Palliative Interventions Tumor Board (200) Moderators: Dimitrios Filippiaidis, MD, PhD, MSc, EBIR, National and Kapodistrian University of Athens; Sean Merrill Tutton, MD, UCSD Health Neuro Palliation, David Prologo, MD, FSIR, Emory University School of Medicine/Emory Healthcare Thoracic Palliation, Vlasios Sotirchos, MD, Memorial Sloan Kettering Cancer Center GI Palliation, Steven Huang, MD, University of Texas MD Anderson Cancer Center MSK Palliation, Alexis Kelekis, MD, PhD, EBIR, FCIRSE, FSIR, National and Kapodistrian University of Athens Tumor Board, All session faculty listed above
	GU, Prostate, and Adrenal Tumor Board (200) Moderators: David Breen, MD, FRCR, University Hospitals Southampton; Matthew Callstrom, MD, PhD, Mayo Clinic T1 Renal Cancer Treatment Decision-making, Ryan Kohlbrenner, MD, University of California San Francisco Renal Tumor Ablation: How to Sort a Contentious Trial, Maxine Tran, MBBS, PhD, FRCS (Urol), University College of London Adrenal Metastases Ablation: Current Status with SBRT and Surgery, Alex King, MBBS, MRCS, FRCR, University Hospitals Southampton MR-Guided Prostate Cancer Ablation: Why, When, and How, David Woodrum, MD, PhD, Mayo Clinic Tumor Board, All session faculty listed above
2:45 - 3:30 p.m.	Exhibit Hall Coffee Break
2:45 - 3:30 p.m.	Discovery Theatre Programming 2:45 - 3:15 p.m. - IO Practice Building: OBLs and More (All levels) Moderators: Tony Brown, MD, RIA Endovascular; S. Andrew Vartanian, MD, PrecisionIR 3:15 - 3:30 p.m. - Product Theatre presented by Siemens Healthineers and Varian, a Siemens Healthineers Company Cryoablation in Breast Cancer Care: Evidence, Outcomes, and Future Directions, Heather Garrett, MD
3:45 - 4:45 p.m.	Ethics in IO (100) Moderators: Eric J. Keller, MD, MA, Delaney Radiology; Hooman Yarmohammdi, MD, Memorial Sloan Kettering Cancer Center Ethical Challenges in Interventional Oncology, Hooman Yarmohammdi, MD, Memorial Sloan Kettering Cancer Center Ethical Quandries, Eric J. Keller, MD, MA, Delaney Radiology; Hooman Yarmohammdi, MD, Memorial Sloan Kettering Cancer Center; Jane Zorzi, BSN, RN, Johns Hopkins University; Nadine Abi-Jaoudeh, MD, University of California Irvine; Tony Brown, MD, RIA Endovascular
	Pancreaticobiliary (200) Moderators: William Rilling, MD, FSIR, Medical College of Wisconsin; Baljendra S. Kapoor, MD, MBA, University of Michigan Hospitals Cholangioscopic Interventions for Malignant Biliary Disease, Ahsun Riaz, MD, Northwestern University Role of Y90 in Cholangiocarcinoma, William Rilling, MD, FSIR, Medical College of Wisconsin Pancreas IRE (CROSSFIRE), Rebekah White, MD, University of California, San Diego Endobiliary Ablation, Hyun Pyon Hong, MD, Kangbuk Samsung Hospital/Sungkyunkwan University School of Medicine Treatment Sequencing in HILAR Disease, Baljendra S. Kapoor, MD, MBA, University of Michigan Hospitals Discussion, All session faculty listed above
	Trials in Progress (100) Moderators: Joseph Erinjeri, MD, PhD, Memorial Sloan Kettering Cancer Center; Philippe L. Pereira, MD, SLK Kliniken GmbH Heilbronn and University Heidelberg REPLACE, Richard S. Finn, MD, Geffen School of Medicine at UCLA CRYOMUNE, Philippe L. Pereira, MD, SLK Kliniken GmbH Heilbronn and University Heidelberg Pulminary TACE Trial, F. Edward Boas, MD, PhD, City of Hope COLLISION, Martijn R. Meijerink, MD, PhD, FCIRSE, Amsterdam UMC Borealis, Afshin Gangi, MD, PhD, University Hospital Strasbourg, King’s College London
5:00 - 6:00 p.m.	HCC Tumor Board (200) Moderators: Laura Crocetti, MD, PhD, EBIR; University of Pisa; Robert Lewandowski, MD, FSIR; Northwestern Medicine Panelists: Francis Yao, MD, University of California San Francisco; Marina Baretti, MD, Johns Hopkins School of Medicine; Parissa Tabrizian, MD, FACS, Mount Sinai Medical Center; Edward Kim, MD, Mount Sinai Health Systems; David Breen, MD, FRCR, University Hospitals Southampton
6:00 - 7:30 p.m.	Science and Industry Welcome Reception All attendees are invited to join us to celebrate the start of the 2025 Annual Meeting. This networking reception will include poster and award presentations in the Exhibit Hall.

Saturday, 1 February 2025

Time		Session Description
7:15 - 8:45 a.m.	Breakfast and Industry Symposium presented by Histosonics - Histotripsy: A Year in Review, Redefining What is Possible Join us for a panel discussion to learn how Histotripsy is driving change in the management of liver tumors Session Panel Joe Herman MD, MSc, MHCM, Medical Director, Histosonics; CMO Canopy Cancer Collective; Adjunct Professor, Radiation Medicine, Northwell Health Paul Laeseke MD, PhD, Associate Professor (Tenure), Interventional Radiology at University of Wisconsin-Madison Christos Georgiades, MD, PhD, Johns Hopkins University, Director of Interventional Oncology, Professor of Radiology and Radiological Science Bruno Odisio, MD, PhD, FSIR, FCIRSE, Professor, Department of Interventional Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX Brian Fuller, MBA, Senior Director of Clinical Operations, Providence Mission Hospital
9:00 a.m. - 5:00 p.m.	Exhibit Hall Open
9:00 - 10:00 a.m.	Intermediate Stage HCC Debate (200) Moderators: Robert Lewandowski, MD, FSIR; Northwestern Medicine; Nishita Kothary, MD, Stanford School of Medicine; Michael C. Soulen, MD, FSIR, FCIRSE, University of Pennsylvania; Marina Baretti, MD, Johns Hopkins School of Medicine HCC within UCSF Criteria: TACE Remains the Optimal Strategy for Downstaging, Christos Georgiades, MD, PhD, Johns Hopkins University HCC within UCSF Criteria: Y90 has Replaced TACE as Optimal Downstaging Strategy, Irene Bargellini, MD, Candiolo Cancer Institute and University of Turin HCC within UCSF Criteria: TACE vs Y90 Discussion, All listed faculty Advanced Multifocal HCC: Combination of TACE and Systemic Therapy is Superior to Y90 Combined with Systemic Therapy, Michael C. Soulen, MD, FSIR, FCIRSE, University of Pennsylvania Advanced Multifocal HCC: Combination of Y90 and Systemic Therapy is Superior to TACE Combined with Systemic Therapy, Evan Lehrman, MD, FSIR, California Pacific Medical Center Advanced Multifocal HCC: TACE or Y90 with Systemic Therapy Discussion, All listed faculty
	Lymphatics (200) Moderators: Max Itkin, MD, University of Pennsylvania; Robert Liddell, MD, Johns Hopkins School of Medicine Thoracic Duct Interventions, Max Itkin, MD, University of Pennsylvania Pelvic Lymph Leak, Robert Liddell, MD, Johns Hopkins School of Medicine Liver Lymphangiography, Protien-losing Enteropathy, and Chylous Ascites, Gregory Nadolski, MD, University of Pennsylvania Malignancy and Lower Extremity Swelling, K. Pallav Kolli, MD, University of California San Francisco
	Biomarkers for Treatment Response (300) Moderators: Terence P. Gade, MD, PhD, University of Pennsylvania; Mishal Mendiratta-Lala, MD, University of Michigan Imaging Biomarkers of Treatment Response in HCC, Mishal Mendiratta-Lala, MD, University of Michigan Neuroendocrine Tumors, Erica Alexander, MD, Memorial Sloan Kettering Cancer Center HCC, Terence P. Gade, MD, PhD, University of Pennsylvania Cholangiocarcinoma, Christina Mosconi, MD, IRCCS, Policlinico di Sant'orsola Bologna ctDNA for GI Malignancies, Adam Burgoyne, MD, PhD, University of California San Diego
10:00 - 10:30 a.m.	Exhibit Hall Coffee Break
10:00 - 10:30 a.m.	Discovery Theatre Programming Building IO in Private Practice: How I Did It (All levels) Moderators: Jonathan Steinberger, MD, Cedars Sinai Medical Center; Charles Nutting, DO, FSIR, Image Guided Therapy
10:30 - 11:30 a.m.	Scientific Oral Abstracts (200) Moderators: Isabel Gala Newton, MD, PhD, VASDMC and UCSD; Nadine Abi-Jaoudeh, MD, University of California Irvine Hepatic Deformable Image Registration Prediction with 3-Dimensional Neural Network to Reduce Ablation Image Processing Time, Xinyue Zhang, MA, The University of Texas MD Anderson Cancer Center; Rice University Randomized Embolization Trial for NeuroEndocrine Tumors (RETNET), Michael C. Soulen, MD, Abramson Cancer Center, University of Pennsylvania Five-year overall survival and overall survival by tumor response measures from the Phase 3 HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma, Farshid Dayyani, MD, PhD, University of California Irvine Adjuvant Immunotherapy After Transarterial Radioembolization in Patients with High-Risk Hepatocellular carcinoma, Josh G. Kim, BA, Icahn School of Medicine at Mount Sinai Percutaneous Cryoablation versus Microwave Ablation for Hepatocellular Carcinoma: Comparative Study of Safety and Oncologic Outcomes, David Dimitris Chlorogiannis, MD, Department of Radiology, Brigham and Women's Hospital Outcomes in patients requiring percutaneous transhepatic biliary drainage post-pancreaticoduodenectomy: a single-center experience, Laurel Chen, MBE, Medical College of Wisconsin Association of Neuroendocrine Liver Tumor Burden with Outcomes after Embolization, PRRT and CapTem, Cathal O'Leary, MB, BCh, BAO, University of Toronto
10:30 - 11:30 a.m.	y90 Dosimetry (200) Moderators: John D. Louie, MD, Stanford University; Beau Toskich, MD, Mayo Clinic Dosimetry Updates: HCC and Cholangiocarcinoma, Ammar Sarwar, MD, FSIR, Beth Israel Deaconess Medical Center/Harvard Medical School Dosimetry Updates for Metastatic Disease, Nima Kokabi, MD, University of North Carolina Chapel Hill Single Session Mapping and Treatment, Edward Kim, MD, Mount Sinai Health Systems Navigating Complex Anatomy, John D. Louie, MD, Stanford University
11:30 a.m. - 1:00 p.m.	Exhibit Hall Open
11:45 a.m. - 12:30 p.m.	Lunch and Industry Symposium presented by Boston Scientific - CATALYZE Y-90: An MDT Roundtable on TheraSphere for HCC Moderator: Riad Salem, MD, MBA, Northwestern Parissa Tabrizian, MD, FACS, Mt. Sinai Medical Center Francis Yao, MD, University of California San Francisco Juan Martin Gimenez, MD, Ochsner Health
11:45 a.m. - 12:30 p.m.	Lunch and Industry Symposium presented by TriSalus - Improving the T:N Ratio in Complex Liver Cancer Patients: A Case-based Discussion Zachary Berman, MD, University of California San Diego Peiman Habibollahi, MD, Memorial Sloan Kettering Cancer Center
12:15 - 1:00 p.m.	Discovery Theatre Programming 12:15 - 12:45 p.m. - Young IO Research Fellowship Presentations (All levels) Moderator: Lynn Savic, MD, Universitätsmedizin Charité Berlin Percutaneous Intratumoral Immunoadjuvant Gel to Increase Checkpoint Inhibitor Response in Pancreatic Cancer Liver Metastases, David Dimitris Chlorogiannis, MD, MSc(c/Res), PhDc, Massachusetts General Hospital, Brigham and Women’s Hospital, Harvard Medical School Exploring the Molecular Signatures of Y-90 Resistance in Hepatocellular Carcinoma: A Translational Approach, Christine Yoon, MS, Albert Einstein College of Medicine 12:45 - 1:00 p.m. - Product Theatre presented by Siemens Healthineers and Varian, a Siemens Healthineers Company Advancing the Needle in Ablation Zone Predictability, Edward Kim, MD, FSIR, Mount Sinai Health Systems; Venkatesh Krishnasamy, MD, FCIRCE, UAB
1:00 - 2:30 p.m.	Lung Tumor Board (200) Moderators: Alda Tam, MD, MD Anderson Cancer Center; Florian J. Fintelmann, MD, Massachusetts General Hospital Treatment Modality Selection for Ablation of Lung Nodules, Damian E. Dupuy, MD, FACR, Cape Cod Hospital and Brown University Advanced Techniques in Lung Ablation, Robert Suh, MD, David Geffen School of Medicine at UCLA Combination of Local and Systemic Therapies, Michael Pritchett, DO, MPH, FirstHealth of the Carolinas and Pinehurst Medical Center Treatment of Oligometastatic Disease in Lung Cancer, Erica Alexander, MD, Memorial Sloan Kettering Cancer Center Tumor Board, All session faculty listed above
1:00 - 2:30 p.m.	mCRC Tumor Board (200) Moderator: Constantinos Sofocleous, MD, PhD, FSIR, FCIRSE, Memorial Sloan Kettering Cancer Center; Bela Kis, MD, PhD, FSIR, Moffitt Cancer Center Current Concepts in Ablation for Colorectal Liver Metastases: Lessons Learned from Recent Trials, Grant Schmidt, MD, Mayo Clinic Combination Therapy: Y90 with Chemotherapy, Suvranu Ganguli, MD, Boston Medical Center/Boston University School of Medicine Oligomets in Colon Cancer, Stephen J. Hunt, MD, PhD, FSIR, University of Pennsylvania Role of Chemoembolization for mCRC, Thomas Vogl, MD, Clinic for Radiology and Nuclear Medicine Tumor Board, All session faculty listed above, Sidharth Anand, MD, MBA, University of California, Los Angeles; Eric Nakakura, MD, PhD, University of California, San Francisco
2:45 - 3:30 p.m.	Exhibit Hall Coffee Break
2:45 - 3:30 p.m.	Discovery Theatre Programming 2:45 - 3:15 p.m. - Trials and Tribulations: Getting Started in Clincal Research (All levels) Moderator: Khashayar Farsad, MD, PhD, Oregon Health and Science University Faculty: Clifford R. Weiss, MD, FSIR, FCIRSE, Johns Hopkins University School of Medicine; Florian J. Fintelmann, MD, Massachusetts General Hospital 3:15 - 3:30 p.m. - Product Theatre presented by RenovoRx Breaking Barriers in Drug Delivery: Trans-arterial Micro-perfusion, Paula Novelli, MD, University of Pittsburgh Medical Center; Khashayar Farsad, MD, PhD, Oregon Health and Science University; David Sperling, MD, FSIR, Columbia University Irving Medical Center
3:45 - 4:45 p.m.	Must-Know Papers (100) Moderators: Rony Avritshcer, MD, MD Anderson Cancer Center; Terence P. Gade, MD, PhD, University of Pennsylvania IMbrave/150/Himalaya Trilas, Joseph Erinjeri, MD, PhD, Memorial Sloan Kettering Cancer Center Intraprocedural versus initial follow-up ablative marigin assessment after mCRC Liver Ablation, Ethan Lin, MD, MD Anderso Cancer Center MRI-guided stereotactic ablative body radiotherapy versus CT-guided pancreatic IRE, Martijn R. Meijerink, MD, PhD, FCIRSE, Amsterdam UMC Sublobar resection, Stereotactic Body Radiation Therapy and Percutaneous ablation for lung cancer, Matthew Callstrom, MD, PhD, Mayo Clinic Percutaneous MWA versus robot-assisted partial nephrectomy for stage I RCC, Dimitrios Filippiaidis, MD, PhD, MSc, EBIR, National and Kapodistrian University of Athens
	IO Essentials Sponsored Content presented by Penumbra (100)
	Hands-on y90 Dosimetry Block 1* (200) *Pre-registration is required to secure a workstation, at no additional fee. Participants will work in pairs to apply contouring principles for practical application. This session will use the MIM software as a primary example. Registrants are strongly encouraged to attend both blocks for a well-rounded educational experience. Additional space will be available for observers based on room capacity. Moderator: Juan Martin Gimenez, MD, Ochsner Health Faculty: Nima Kokabi, MD, University of North Carolina Chapel Hill; Tyler Sandow, MD, Ochsner Health; David S. Wang, MD, FSIR, Stanford Medicine; Ammar Sarwar, MD, FSIR, Beth Israel Deaconess Medical Center/Harvard Medical School; Beau Toskich, MD, Mayo Clinic; Venkatesh Krishnasamy, MD, FCIRSE, UAB
5:00 - 6:30 p.m.	Ablation vs. Radiation Debate: SIO Meets ASTRO (200) Moderators: Muneeb Ahmed, MD, FSIR, Beth Israel Deaconess Medical Center/Harvard Medical School; David Breen, MD, FRCR, University Hospitals Southampton; Jack Jennings, MD, PhD, FACR, FSIR, FCIRSE, Washington University Liver: y90 Rad Seg vs. SBRT, Riad Salem, MD, MBA, Northwestern and Mekhail Anwar, MD, PhD, UC San Francisco and UC Berkeley Renal Cancer, Thomas Atwell, MD, FSIR, Mayo Clinic and Chad Tang, MD, MD Anderson Cancer Center Spinal Palliative, Jason R. Levy, MD, FSIR, Northside Hospital and James Urbanic, MD, University of California San Diego
6:30 - 7:15 p.m.	Industry Member Reception* *by invitation only

Sunday, 2 February 2025

Time		Session Description
8:00 - 8:45 a.m.	Breakfast and CME Session: Optimal Preparation and Treatment Endpoints in cTACE (200) Breakfast will be provided. Following the overview, participants will engage in hands-on learning at workstations supervised by expert faculty Overview, Michael C. Soulen, MD, FSIR, FCIRSE, University of Pennsylvania Faculty: Nicholas Fidelman, MD, University of California San Francisco; Irene Bargellini, MD, Candiolo Cancer Institute and University of Turin; Nishita Kothary, MD, Stanford School of Medicine; Juan Martin Gimenez, MD, Ochsner Health; William Rilling, MD, FSIR, Medical College of Wisconsin; Tyler Sandow, MD, Ochsner Health; Vijay Ramalingam, MD, FSIR, Beth Israel Deaconess Medical Center/Harvard Medical School; Nadine Abi-Jaoudeh, MD, University of California Irvine; Gregory Nadolksi, MD, University of Pennsylvania; Robert Lewandowski, MD, FSIR, Northwestern Medicine; Daniel Sze, MD, PhD, Stanford Univeristy; Resmi Charalel, MD, MPH, Weill Cornell Medicine
9:00 a.m. - 5:00 p.m.	Exhibit Hall Open
9:00 - 10:00 a.m.	IO Essentials: Exploring the Role of Multi-modality Therapies in HCC: Breaking Barriers (100) Joseph Erinjeri, MD, PhD, Memorial Sloan Kettering Cancer Center Michael C. Soulen, MD, FSIR, FCIRSE, University of Pennsylvania This session is supported by an educational grant from AstraZeneca
	BCLC C HCC Debate "Who's on First?" (200) Moderators: Riad Salem, MD, MBA, Northwestern; Roberto Iezzi, MD, FCIRSE, Policlinico A Gemelli - IRCCS - Università Cattolica Lobar or Sublobar Portal Vein Invasion, Gregory Nadolksi, MD, University of Pennsylvania and Amit Singal, MD, UT Southwestern Medical Center Bilobar or Main Portal Vein Invasion, Daniel Sze, MD, PhD, Stanford University and Marina Baretti, MD, Johns Hopkins School of Medicine Patients with Vascular Invasion and Regional Metastases, Guy Johnson, MD, PharmD, University of Washington and Richard S. Finn, MD, Geffen School of Medicine at UCLA
	Robotics, Navigation, Guidance, and Confirmation (200) Moderators: Bruno C. Odisio, MD, PhD, FSIR, MD Anderson Cancer Center; Nadine Abi-Jaoudeh, MD, University of California Irvine Augmented Reality, Terence P. Gade, MD, PhD, University of Pennsylvania Technical Principles of Navigation, Iwan Paolucci, PhD, D Anderson Cancer Center Procedure Planning and Guidance, Nadine Abi-Jaoudeh, MD, University of California Irvine Robotics, Luigi A.Solbiati, MD, Humanitas University and Research Hospital Confirmation, Bruno C. Odisio, MD, PhD, FSIR, MD Anderson Cancer Center
10:00 - 10:30 a.m.	Exhibit Hall Coffee Break
10:00 - 10:30 a.m.	Discovery Theatre Programming Internet: Friend or Foe? (All levels) Moderator: Julius Chapiro, MD, PhD, Yale University School of Medicine Faculty: Dianne Keen, FRMBA, AbbaDox; Nadine Abi-Jaoudeh, MD, University of California Irvine
10:30 - 11:30 a.m.	Scientific Oral Abstracts (200) Moderator: Isabel Gala Newton, MD, PhD, VASDMC and UCSD The Phase 3 LEAP-012 Study: Transarterial Chemoembolization With or Without Lenvatinib Plus Pembrolizumab for Intermediate-Stage Hepatocellular Carcinoma, Richard S. Finn, MD, Geffen School of Medicine at UCLA Safety and treatment response of Pulsed electric field (PEF) ablation therapy for Recurrent Malignant Pleural Mesothelioma (MPM), Shahed Tappuni, MD, University of California Los Angeles Safety of CT-guided pulsed electrical field ablation adjacent to sensitive intrathoracic structures for treatment of intrathoracic malignancies, Robert Ryan Meyerhoff, MD,PhD, Duke University MR-Guided Cryoablation of Seminal Vesicles: A 10-Year Experience, Ali Ganjizadeh, MD, Mayo Clinic Rochester MR-guided Cryoablation in the Treatment of Recurrent Prostate Cancer in the Prostate Bed: An 11-Year Prospective Study, Setayesh Sotoudehnia Korani, SS, Mayo Clinic Rochester Outcomes of thermoprotective techniques in image-guided ablation of musculoskeletal tumors, Carl Stokes, MD, Mallinckrodt Institute of Radiology- Washington University School of Medicine in St. Louis Irreversible Electroporation in the Canine Spine: Impact on Implanted Tumors and Adjacent Structures, Koustav Pal, MBBS, Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center
10:30 - 11:30 a.m.	y90 Clinical Applications (200) Moderators: Charles Y. Kim, MD, Duke University; Robert Lewandowski, MD, FSIR; Northwestern Medicine Strategies for Diffuse Bilobar Disease, Charles Y. Kim, MD, Duke University Approach to Challenging Patients, Thomas Helmberger, MD, PhD, Munich Klinik Bogenhausen Extra-hepatic Applications, Robert Lewandowski, MD, FSIR; Northwestern Medicine Holmium-166 and the RALLY Study, Marnix Lam, MD, PhD, University Medical Center Utrecht
11:30 a.m. - 1:00 p.m.	Exhibit Hall Open
11: 45 a.m. - 12:30 p.m.	Lunch and Industry Symposium presented by Siemens Healthineers and Varian, a Siemens Healthineers Company - Connecting the Power of Collaboration, Imaging, and Therapy: Delivering the Future of Palliative Patient Care Moderator: Theresa Caridi, MD FSIR, University of Alabama Director of Medical Affairs, Varian Medical Systems Breaking the Ice: A Review of Musculoskeletal Cryoablation Literature, Merve Ozen, MD, Mayo Clinic Arizona Harnessing Imaging and Therapy to Improve Workflow and Drive Patient Outcomes, Scott Genshaft, MD, UCLA Health The Future of Evidence in Multidisciplinary Oncologic Pain Palliation, Jack Jennings, MD, PhD, FACR, FSIR, FCIRSE, Washington University Improving Patient Satisfaction through Multidisciplinary Care: The Intersection of Radiation and Interventional Oncology, Dee Khuntia, MD, FASTRO, Senior Vice President, Chief Medical Officer, Varian Medical Systems
11: 45 a.m. - 12:30 p.m.	Lunch and Industry Symposium presented by Stryker Bone Tumor Ablation feat. Stryker OptaBlate and Vertebral Augmentation feat. Stryker SpineJack, Jason R. Levy, MD, FSIR, Northside Hospital
12:15 - 1:00 p.m.	Discovery Theatre Programming 12:30 - 1:00 p.m. - Industry Abstract Presentations (All levels) Moderator: Isabel Gala Newton, MD, PhD, VASDMC and UCSD Primary efficacy, safety, survival and initial biomarker data from the registration-intended cohort of patients with anti–PD-1–failed melanoma from the IGNYTE clinical trial with RP1 combined with nivolumab, Gino K. In, MD, University of Southern California Norris Comprehensive Cancer Center CryoSYNC Gel: A Novel CT-responsive, Biocompatible Nanogel to Enhance Performance of Cryoablation, William Park, PhD, Theromics Inc. Micro-CT imaging following intra-arterial delivery of a radiopaque silicone polymer using a double-balloon occlusion catheter in pigs: A model to analyze tissue penetration via the trans-arterial micro perfusion (TAMP) technique, Paula Novelli, MD, University of Pittsburgh Medical Center Preliminary Safety and Efficacy Data for Microwave Ablation of Liver Tumors from the Global, Multicenter NEUWAVE™ Observational Liver Ablation (NOLA) Registry, Nikolaos Fotiadis, MD, FRCR, EBIR, The Royal Marsden Hospital
1:00 - 2:30 p.m.	Future Liver Remnant (200) Moderator: Peiman Habibollahi, MD, MD Anderson Cancer Center; Nishita Kothary, MD, Stanford School of Medicine Surgical Techniques and Estimation of Functional Liver Reserve, Eric Nakakura, MD, PHD, University of California San Francisco PVE: Which Embolic to Choose? Jose Hugo Luz, MD, PhD, SOBRICE, FCIRSE, INCA Brazilian National Cancer Institute Total Venous Deprivation, Francesco de Cobelli, MD, San Raffaele Hospital and Salute University Radiation Lobectomy: Updates and Trials in Progress, Resmi Charalel, MD, MPH, Weill Cornell Medicine
	MSK Tumor Board (200) Moderators: Afshin Gangi, MD, PhD, University Hospital Strasbourg, King’s College London; Brandon M. Key, MD, Medical College of Wisconsin Pathalogic Fractures: IR Approach, Steven Yevich, MD, MPH, MD Anderson Cancer Center Pathalogic Fractures: Orthopedic Approach, Melissa Zimel, MD, University of California San Francisco Ablation and Vertebral Augmentation: Neuroprotective Techniques, Jack Jennings, MD, PhD, FACR, FSIR, FCIRSE, Washington University Electrochemotherapy, Frederic Deschampes, MD, PhD, Gustave Roussy Tumor Board, All session faculty listed above, Christian Meyer, MD, PhD, Johns Hopkins Hospital
	Robotics, Navigation, Guidance, and Confirmation Hands-on (All levels) Moderator: Bruno C. Odisio, MD, PhD, FSIR, MD Anderson Cancer Center Faculty: Iwan Paolucci, PhD, D Anderson Cancer Center; Francois H. Cornelis, MD, PhD, Memorial Sloan Kettering Cancer Center; Keith M. Horton, MD, FSIR, MedStar Health/Georgetown University School of Medicine; Luigi A.Solbiati, MD, Humanitas University and Research Hospital; Stephen J. Hunt, MD, PhD, FSIR, University of Pennsylvania; Alex King, MBBS, MRCS, FRCR, University Hospitals Southampton; Sean Merrill Tutton, MD, UCSD Health
2:45 - 3:30 p.m.	Exhibit Hall Coffee Break
2:45 - 3:30 p.m.	Discovery Theatre Programming 2:45 - 3:15 p.m. - IO in OBL (All levels) David Sperling, MD, FSIR, Columbia University Irving Medical Center; Scott Genshaft, MD, UCLA; Jayson S. Brower, MD, Inland Imaging 3:15 - 3:30 p.m. - SIO Clinical Trial Collaborative Update
3:45 - 4:45 p.m.	SIO Grants (200) Moderators: Julius Chapiro, MD, PhD, Yale University School of Medicine; Christopher D. Malone, MD, Mallinckrodt Institute of Radiology, Washington University School of Medicine 2023 Grant Update: Spatial proteogenomics for prediction of response in combined radioembolization and immunotherapy of HCC, Elif Öcal, MD, LMU 2022 Grant Update: Stoking an Anti-Liver Cancer Immune Response with Cryoablation Plus Intratumoral Immunostimulant, Isabel Gala Newton, MD, PhD, VASDMC and UCSD 2022 Grant Update: Engineered Extracellular Vesicles to Modulate Immunotherapy in Liver Cancer, Kiyoyuki Minamiguchi, MD, PhD, Nara Medical University 2022 Grant Update: Single Cell Analysis of Combined Thermal Ablation and Immunotherapy of HCC, S. Nahum Goldberg, MD, Beth Israel Deaconess Medical Center/Harvard Medical School 2022 Grant Update: Immunobiologic and Metabolic Determinants of Response to Combination Locoregional and Immunotherapy in HCC, David Tischfield, MD, PhD, University of Pennsylvania Interactive Debate, All Supported by an educational grant from AstraZeneca.
	Melanoma (200) Moderators: David J. Eschelman, MD, FSIR, Sidney Kimmel Medical College of Thomas Jefferson University, Thomas Jefferson University Hospital; Gloria Hwang, MD, FSIR, Stanford University Building a Multidisciplinary Melanoma Program, Robert Adamo, MD, Thomas Jefferson University Hospital Relative Advantages of Chemoembolization and Immunoembolization, David J. Eschelman, MD, FSIR, Sidney Kimmel Medical College of Thomas Jefferson University, Thomas Jefferson University Hospital Y90 with or without Immunotherapy, Gloria Hwang, MD, FSIR, Stanford University Ablative Techniques with or without Immunotherapy, Chenyang Zhan, MD, PhD, Memorial Sloan Kettering Cancer Center Percutaneous Hepatic Perfusion with Melphalan, Alexander Villalobos, MD, University of North Carolina Chapel Hill
	Hands-on y90 Dosimetry Block 2* (200) *Pre-registration is required to secure a workstation, at no additional fee. Participants will work in pairs to apply contouring principles for practical application. This session will use the Simplicit90Y software as a primary example. Registrants are strongly encouraged to attend both blocks for a well-rounded educational experience. Additional space will be available for observers based on room capacity. Moderator: Juan Martin Gimenez, MD, Ochsner Health; Faculty: Tyler Sandow, MD, Ochsner Health; David S. Wang, MD, FSIR, Stanford Medicine; Beau Toskich, MD, Mayo Clinic; Diana Dinh, MD, MPH, Beth Israel Deaconess Medical Center; Marnix Lam, MD, PhD, University Medical Center Utrecht; Venkatesh Krishnasamy, MD, FCIRSE, UAB
5:00 - 6:00 p.m.	Oligometastatic Disease Tumor Board (200) Moderators: Martijn R. Meijerink, MD, PhD, FCIRSE, Amsterdam UMC; Alexios Kelekis, MD, PhD, EBIR, FCIRSE, FSIR, National and Kapodistrian University of Athens; A. Nick Kurup, MD, Mayo Clinic Panelists: Afshin Gangi, MD, PhD, University Hospital Strasbourg, King’s College London; Mekhail Anwar, MD, PhD, UC San Franscico and UC Berkeley; Christian Meyer, MD, PhD, Johns Hopkins Hospital
7:00 - 10:00 p.m.	*Sunday Soiree at Alexxa's Las Vegas** *Attendance requires an additional fee.

Monday, 3 February 2025

Time	Session Description
7:30 - 8:30 a.m.	Breakfast
8:30 - 10:30 a.m.	Practical IO (All levels) Moderators: Nicholas Fidelman, MD, University of California San Francisco; Aneesa Majid, MD, MBA, Independent Case presentations by: Vladimir Sheynzon, MD, MBA, Columbia University Irving Medical Center Gaby E. Gabriel, MD, FSIR, University of Kentucky Gina Landinez, MD, MCVI MCI David S. Wang, MD, FSIR, Stanford Medicine Scott Genshaft, MD, UCLA Rajesh Shah, MD, UCSF Eric Wehrenberg-Klee, MD, Massachusetts General Hospital Ahmad Parvinian, MD, Mayo Clinic James Ronald, MD, PhD, Duke University Tony Brown, MD, RIA Endovascular Todd Schlachter, MD, Yale School of Medicine Jin Woo Choi, MD, PhD, Seoul National University Hospital
11:00 a.m. - 1:00 p.m.	Case-based Review: M&M (All levels) Moderators: Daniel Sze, MD, PhD, Stanford University; Charles Nutting, DO, FSIR, Image Guided Therapy Case presentations by: Jeffrey Weinstein, MD, FSIR, Beth Isreal Deaconess Medical Center/Harvard Medical School Matthew J. Scheidt, MD, FSIR, Froedtert and the Medical College of Wisconsin Jonathan Kessler, MD, City of Hope Ken Zhao, MD, Memorial Sloan Kettering Cancer Center Igor Latich, MD, Yale University Kirema Garcia-Reyes, MD, Icahn School of Medicine at Mount Sinai Alex King, MBBS, MRCS, FRCR, University Hospitals Southampton Lambros Tselikas, MD, PhD, Gustave Roussy Jonathan Morris, MD, Mayo Clinic Juan Carlos Perez Lozada, MD, Yale School of Medicine Donna D'Souza, MD, FSIR, University of Minnesota Elena Violari, MD, Radiology Partners, Franciscan Alliance Hospitals

Time

Session Description

7:30 - 8:30 a.m.

Breakfast

8:30 - 10:30 a.m.

Practical IO (All levels)

Moderators: Nicholas Fidelman, MD, University of California San Francisco; Aneesa Majid, MD, MBA, Independent

Case presentations by:

Vladimir Sheynzon, MD, MBA, Columbia University Irving Medical Center
Gaby E. Gabriel, MD, FSIR, University of Kentucky
Gina Landinez, MD, MCVI MCI
David S. Wang, MD, FSIR, Stanford Medicine
Scott Genshaft, MD, UCLA
Rajesh Shah, MD, UCSF
Eric Wehrenberg-Klee, MD, Massachusetts General Hospital
Ahmad Parvinian, MD, Mayo Clinic
James Ronald, MD, PhD, Duke University
Tony Brown, MD, RIA Endovascular
Todd Schlachter, MD, Yale School of Medicine
Jin Woo Choi, MD, PhD, Seoul National University Hospital

11:00 a.m. - 1:00 p.m.

Case-based Review: M&M (All levels)

Moderators: Daniel Sze, MD, PhD, Stanford University; Charles Nutting, DO, FSIR, Image Guided Therapy

Case presentations by:

Jeffrey Weinstein, MD, FSIR, Beth Isreal Deaconess Medical Center/Harvard Medical School
Matthew J. Scheidt, MD, FSIR, Froedtert and the Medical College of Wisconsin
Jonathan Kessler, MD, City of Hope
Ken Zhao, MD, Memorial Sloan Kettering Cancer Center
Igor Latich, MD, Yale University
Kirema Garcia-Reyes, MD, Icahn School of Medicine at Mount Sinai
Alex King, MBBS, MRCS, FRCR, University Hospitals Southampton
Lambros Tselikas, MD, PhD, Gustave Roussy
Jonathan Morris, MD, Mayo Clinic
Juan Carlos Perez Lozada, MD, Yale School of Medicine
Donna D'Souza, MD, FSIR, University of Minnesota
Elena Violari, MD, Radiology Partners, Franciscan Alliance Hospitals

Additional Meeting Opportunities

Thursday, 30 January 2025

IO Essentials

IO Essentials is designed specifically for medical students, fellows, residents, and early career IO practitioners. Apply to join our cohort of IO Essentials scholars, and take advantage of content and networking opportunities developed just for you!

Learn More

Y90 Master Class

Head, Neck, and Thyroid Ablation Master Class

In response to the rapid expansion of head, neck, and thyroid ablation practices, SIO is excited to host a half-day Head, Neck, and Thyroid Ablation Master Class on Thursday, 30 January 2025.

Learn More

Saturday, 1 February 2025

Y90 Master Class

Breast Cryoablation Mini Master Class

In response to a successful first for a major radiology society in 2024, SIO will host a second hands-on Breast Cryoablation Master Class in conjunction with the SIO 2025 Annual Scientific Meeting on Saturday, 1 February 2025.

Learn More